Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

90.21
Delayed Data
As of Jul 29
 +2.09 / +2.37%
Today’s Change
55.00
Today|||52-Week Range
133.62
-16.82%
Year-to-Date
ARIAD's (ARIA) Stock Up on Q2 Earnings & Revenue Beat
Jul 29 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?
Jul 21 / Zacks.com - Paid Partner Content
Why Ariad Pharmaceuticals Shares Jumped 12.5% Today
Jul 28 / MotleyFool.com - Paid Partner Content
Is Agenus or Ariad Pharmaceuticals the Better Long-Term Buy?
Jul 19 / MotleyFool.com - Paid Partner Content
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise?
Jul 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close88.12
Today’s open88.52
Day’s range86.67 - 90.35
Volume859,753
Average volume (3 months)1,146,019
Market cap$16.9B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+210.00%
Earnings growth (next 5 years)+118.55%
Revenue growth (last year)+47.36%
P/E ratio347.0
Price/Sales26.95
Price/Book98.38

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+1.22+1.24%
PRGOPerrigo Company PLC+0.31+0.34%
MDVNMedivation Inc+1.50+2.40%
MYLMylan NV+0.07+0.15%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers

Search for Jobs